These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11901060)

  • 1. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study.
    Bozzini C; Girelli D; Tinazzi E; Olivieri O; Stranieri C; Bassi A; Trabetti E; Faccini G; Pignatti PF; Corrocher R
    Clin Chem; 2002; 48(4):622-8. PubMed ID: 11901060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease.
    Nassar BA; Zayed EM; Title LM; O'Neill BJ; Bata IR; Kirkland SA; Dunn J; Dempsey GI; Tan MH; Johnstone DE
    Can J Cardiol; 1998 Feb; 14(2):215-20. PubMed ID: 9520858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center.
    Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
    Am J Med; 2002 Oct; 113(6):472-9. PubMed ID: 12427496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemochromatosis gene mutations and risk of coronary artery disease.
    Battiloro E; Ombres D; Pascale E; D'Ambrosio E; Verna R; Arca M
    Eur J Hum Genet; 2000 May; 8(5):389-92. PubMed ID: 10854101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study.
    Claeys D; Walting M; Julmy F; Wuillemin WA; Meyer BJ
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():3-8. PubMed ID: 11886425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
    Chan AT; Ma J; Tranah GJ; Giovannucci EL; Rifai N; Hunter DJ; Fuchs CS
    J Natl Cancer Inst; 2005 Jun; 97(12):917-26. PubMed ID: 15956653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease.
    Beutler E; Felitti V; Ho NJ; Gelbart T
    Acta Haematol; 2002; 107(3):145-9. PubMed ID: 11978935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population.
    Rossi E; Bulsara MK; Olynyk JK; Cullen DJ; Summerville L; Powell LW
    Clin Chem; 2001 Feb; 47(2):202-8. PubMed ID: 11159767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curaçao patients with coronary artery disease have a higher prevalence of the HFE C282Y mutation.
    Dijck-Brouwer DA; Hepkema BG; van der Dijs FP; Steward HN; de Windt-Hol JM; Muskiet FA
    West Indian Med J; 2004 Jun; 53(3):143-6. PubMed ID: 15352740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
    Adams PC; Chakrabarti S
    Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes.
    Mariani R; Pelucchi S; Arosio C; Coletti S; Pozzi M; Paolini V; Trombini P; Piperno A
    Blood Cells Mol Dis; 2010 Mar; 44(3):159-63. PubMed ID: 20117027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.
    Rasmussen ML; Folsom AR; Catellier DJ; Tsai MY; Garg U; Eckfeldt JH
    Atherosclerosis; 2001 Feb; 154(3):739-46. PubMed ID: 11257277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
    Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.
    Kennish L; Attur M; Oh C; Krasnokutsky S; Samuels J; Greenberg JD; Huang X; Abramson SB
    BMC Musculoskelet Disord; 2014 Jan; 15():8. PubMed ID: 24401005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.